Week In Review: Two Major China CROs Move Toward China Public Listings
March 25, 2017 at 14:25 PM EDT
Wuxi AppTec, China's largest CRO/CMO, has begun the application process for an IPO on a China exchange. ShangPharma will combine all of its CRO/CMO operations under the ChemPartner name and merge the entity, with a public company.
